BioSpace News Archive

Deals

Trellis Rx Helps Patients Secure More Than $13.5 Million in Financial Assistance for Specialty Medications in First Ten Months Of 2019

As more health systems adopt company’s medically integrated care model, patients nationwide are benefiting from integrated specialty pharmacy care

December 3, 2019
·
4 min read
Genetown

FORMA Therapeutics Announces Upcoming Presentations at the 31st Annual Piper Jaffray Healthcare Conference and the 2019 ASH Annual Meeting

FORMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that the company will present at two meetings in December

December 3, 2019
·
1 min read
Business

MORE Health Welcomes Regional Vice Presidents David Thomson and Christopher Johnston to the team

MORE Health, a medical Co-Diagnosis and second opinion global healthcare company, announces that David Thomson and Christopher Johnston have joined the team as Regional Vice Presidents to expand its presence into the Texas and Michigan markets.

December 3, 2019
·
2 min read
Policy

OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder

OWP Pharmaceuticals, Inc. announced that it has received Investigational New Drug approval from the U.S. Food and Drug Administration, and has submitted for U.S. patent protection, for the first-ever liquid formulation of lamotrigine.

December 3, 2019
·
4 min read
Policy

Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101

First IND clearance of a clinical candidate derived from Atreca’s differentiated drug discovery platform

December 3, 2019
·
4 min read
Drug Development

Dermavant Announces First Patient Dosed in Phase 2a Clinical Trial of Topical Dual JAK/Syk Inhibitor Cerdulatinib for Vitiligo

Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, announced that the first patient has been dosed in its Phase 2a vitiligo clinical trial for topical cerdulatinib.

December 3, 2019
·
4 min read
Policy

Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975

Patent Underpins CNTX-4975 Formulation Technology and Provides Intellectual Property Protection into 2037

December 3, 2019
·
5 min read
Pharm Country

Lively Donating $100 to the Hearing Loss Association of America for Hearing Aids Sold on Giving Tuesday 2019Donations Take Effect and Customers Also Receive $100 Off Their Purchase When Using the Coupon Code GIVE100GET100

Lively Hearing Corp. announced it will donate $100 to the Hearing Loss Association of America for each pair of hearing aids it sells on Giving Tuesday with code GIVE100GET100.

December 3, 2019
·
2 min read
Business

Outlook Therapeutics Receives FDA Agreement for Three Special Protocol Assessments for Additional Planned Clinical Trials of ONS-5010

ONS-5010, an investigational ophthalmic formulation of bevacizumab for retinal indications, is currently in two clinical trials to treat wet age-related macular degeneration (wet AMD – NORSE 1 and 2).

December 3, 2019
·
7 min read
Kane Biotech Announces Conditional Research Award of Up To $3.4 Million

Kane Biotech Inc. announced that it has been selected to receive a potential award of up to approximately $3.4 million from an unnamed government agency related to the continuing clinical development of the Company’s DispersinB® to treat biofilm mediated antimicrobial resistance in non-healing chronic wounds.

December 3, 2019
·
3 min read